AcquiredStartups
Home/India/Healthtech & bio
Acquisition · Healthtech & bio · India

Cent acquires AI radiology reporting startup Medsee as it raises $15 million Series A

The preventive-health company started by Practo co-founder Shashank ND is buying software that drafts radiology reports, as its full-body scans pass 10,000.

ASAcquired deals deskIndia27 October 2026 · 4 min read
Cent acquires Medsee
Photo: habiloid / Wikimedia Commons, CC BY-SA 2.0

Cent, a Bengaluru preventive-health startup founded by Practo co-founder Shashank ND, has acquired Medsee, a company whose AI software drafts radiology reports for doctors to review. Cent announced the purchase on October 27, 2026, together with a $15 million Series A round co-led by Blume Ventures and South Park Commons.

Neither company disclosed the terms of the acquisition. Reports on the deal did not say how many Medsee staff are joining Cent or whether Medsee will keep selling its software to other customers.

Cent runs full-body screening for people who have no symptoms, and each visit produces a large set of MRI, CT and other scans that radiologists must read. The company said Medsee would help it keep reporting fast and consistent as the number of scans grows.

What Medsee built

Medsee was founded by Chitra Singh, according to Analytics India Magazine and Entrepreneur India. Its platform produces a draft of a structured radiology report and highlights findings, which a qualified radiologist then reviews. Digital Health News reported that the tool is meant to help radiologists read scans and write reports more quickly, while clinicians keep the final decision.

The reports did not give Medsee's founding year, where it is based, how much money it had raised or the size of its team.

Medsee's product works on the reporting step: turning what a radiologist sees in the images into a written, structured report. The radiologist remains responsible for checking the draft and signing off on the findings.

“India's healthcare system is still built to treat illness, not to find it early.”Anshul Khandelwal, Co-founder, Cent

Why Cent is buying

Cent's main product, called Cent Check, combines a full-body MRI, a low-dose CT scan, a DEXA bone scan, an ECG and an echocardiogram with more than 100 blood biomarkers in a single visit of about two hours, Analytics India Magazine reported. Inc42 said the check costs ₹27,500 (about $310) and screens for more than 300 conditions, including heart disease, cancer and neurological disorders. Specialist doctors review the combined results and give each member a health plan.

Each of those visits generates several imaging studies that need a written report. Shashank told Entrackr that buying Medsee would strengthen Cent's AI capabilities, and the company said the software would make reporting faster and more consistent as volumes rise.

Cent has completed about 10,000 scans so far at its own centres in Bengaluru, Mumbai and Delhi NCR and through partner diagnostic labs. The company says roughly one in four people screened had a finding that needed medical attention and about one in 40 needed to see a doctor immediately. Digital Health News reported that more than 2,500 people had major findings and nearly 350 had potentially life-threatening conditions, many of which they had not known about.

Cent has set a target of 10 million scans by 2035 and says it wants to help save one million lives through early detection by then.

The founders and the funding

Cent was founded in 2025 by Shashank ND, Anshul Khandelwal, the former chief marketing officer of Ola Electric, and Arpit Garg, the former head of product at Lenskart, according to Digital Health News and Analytics India Magazine. Garg announced the funding and the acquisition on LinkedIn.

The $15 million Series A, about ₹143 crore, includes both equity and debt, Analytics India Magazine and Entrepreneur India reported. South Park Commons was already an investor. Individual investors in the round include former Vodafone chief executive Arun Sarin, Srinivas Narayanan, formerly OpenAI's chief technology officer for B2B, Sharath Narayana, Aprameya Radhakrishna and Krishna Sridhar. Cent previously raised a $5 million seed round from OneFlow Holdings and South Park Commons, Inc42 reported.

The company said it will spend the new money on research and development and on hiring for its AI, engineering and clinical teams. Entrackr reported that the funds will also go into hardware and clinical research.

Karthik Reddy, co-founder and managing partner of Blume Ventures, said the firm saw in the founders "an obsessive ambition to solve for accurate diagnosis", according to Entrepreneur India. Analytics India Magazine reported that he also pointed to a possible expansion beyond India.

A push into preventive screening

Cent's founders argue that India's health system is set up to treat disease after symptoms appear. "India's healthcare system is still built to treat illness, not to find it early," Khandelwal said. "Our first 10,000 scans have shown us how much that shift is needed."

Entrackr cited estimates that about 101 million people in India have diabetes, 136 million have prediabetes and about 315 million have hypertension, conditions that often go undiagnosed for years.

Shashank is also returning to a bigger role at Practo, the doctor booking and health records company he co-founded. In September 2026, Practo named him managing director and executive chairman and appointed Jagnoor Singh as chief executive, Entrackr reported.

The Medsee deal brings report drafting in-house at a company whose service depends on radiologists reading thousands of full-body scans.

Sources